SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community anticipates a listing on BiFinance and an upcoming airdrop at 5M MC, with some suggesting more CEX listings are on the horizon. Community members highlight the project's organic growth, dedicated development team, and the ongoing "Biggest Buy Contest." The community emphasizes that $BROKE.X has a strong community and the project has been grinding for 9 months.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community buzzes about a potential breakout and the start of "wagmi szn," with many highlighting accumulation from smart money in related tokens like $WAGMI. Recent news of Galaxy Digital's significant SOL purchases and corporate treasury investments have amplified the positive sentiment. The community speculates on further price appreciation as Solana gains traction and increased institutional interest.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is trending as the community rallies around its potential as the next big meme coin on the Solana blockchain, drawing comparisons to $SHIB.X. Discussions highlight the strong community, organic growth, and the simple narrative: 'We're All Gonna Make It,' with many rolling profits into $WAGMI.X in anticipation of a breakout.

Bitmine Immersion Technologies, Inc. is a blockchain technology company, which engages in industrial scale digital asset mining, equipment sales, and hosting operations. It operates through the Cryptocurrency Mining Industry segment. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

BMNR is trending as community members discuss its correlation to Ethereum's potential breakout and Tom Lee's involvement. Some anticipate significant gains, drawing comparisons to other crypto-related stocks like MSTR and SBET, while others point to potential resistance levels. The stock's relationship with ETH and its treasury strategy remain central talking points.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates potential upside from a recently approved ETF, with some traders speculating on targets. Bullish sentiment is fueled by discussions around institutional investment and comparisons to other cryptocurrencies. Some community members are also comparing Dogecoin's potential to that of Bitcoin in its early days.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. is trending due to the completion of its merger with Strive Enterprises, with the combined entity set to focus on building a Bitcoin treasury. The community is discussing potential short squeezes, the impact of the new CUSIP, and speculation around future price targets. Concerns around potential dilution from warrants are also being weighed against the company's access to significant capital.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma ($ATYR) is trending as investors anticipate Phase 3 data, with community discussions focused on the timing of the data release and its potential impact. A recently initiated Overweight rating from Cantor Fitzgerald has fueled speculation about positive trial outcomes, while some traders are weighing the possibility of a short squeeze amid high short interest and option premiums. The stock's binary event nature is also sparking debate on potential price movements based on the data's strength.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to a recently announced $20 million investment agreement, sparking significant price movement and high volatility. Community members are actively discussing potential short squeezes, upcoming news catalysts, and the stock's low float, while also debating entry and exit strategies amidst the price swings. Some traders are drawing comparisons to other high-flying stocks and anticipating further gains.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid discussions around COVID-19 vaccine safety and potential market impacts following reports of government scrutiny and leadership changes at the CDC. Community members are weighing the impact of these events alongside Pfizer's broader pipeline, dividend yield, and potential M&A activity, particularly in oncology and weight loss, as catalysts for future growth. The stock's price movement and potential for a shift away from COVID-related revenues are also being closely monitored.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending following UK regulatory approval for its acquisition of Oxford Ionics and the launch of IonQ Federal, a new unit targeting U.S. government contracts. The community is actively discussing the potential future use cases of quantum computing and whether the current valuation is justified. There are debates around the company's financial performance and the long-term viability of quantum technology.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Catalent Announces New Board Appointments

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has appointed Susan Mahony, Marie-France Tschudin and Tim...

Lennox International Set to Join SandP 500 and BILL Holdings to Join SandP MidCap 400

Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400 Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400 PR Newswire NEW YORK, Dec. 18, 2024...

Novo Holdings Completes Acquisition of Catalent

Catalent, Inc. (Catalent), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences investment firm...

US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut

US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut

 The last full week of 2024 started off with a burst of US exceptionalism which helped US equity futures shrug...

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction

Catalent, Inc. (Catalent, NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences...

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

QuidelOrtho Corporation (Nasdaq: QDEL) (the Company or QuidelOrtho), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction

Catalent, Inc. Reports First Quarter Fiscal 2025 Results

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the first quarter of fiscal 2025...

Super Micro shares tumble following disturbing news

Analysts at Needham had seen enough.The investment firm said on Oct. 30 that it was suspending its buy rating of Super Micro Computer (SMCI) shares after the maker of liquid-cooled...

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised concerns over the Catalent acquisition.
read more...

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.

Current Price	$63.49
Prev Close	$63.48
Open	$63.48
Dividend Yield	0.00%
50-Day Moving Average	$60.41
Beta	1.11
Avg. Volume	1.91M
PE Ratio	-27.97

52-Week High	$63.50
52-Week Low	$42.11
Market Capitalization	$11.52B
EPS (Annual)	-$5.76
Price to Book	3.25
Revenue Per Employee	$259,230.77
Enterprise Value/EBITDA	N/A

CTLT
Catalent Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTLT News

CTLT Catalent Inc.